Seeking Alpha

iShares Nasdaq Biotechnology (IBB)

()

Instablog posts on IBB

  • 8 HealthCare Stocks With 3%+ Dividends by Hao Jin
    In 3 of the past 4 market rebounds since 1982, equity gains slowed to a single digit pace in the 2nd year, after the initial rally. Now dividend stocks have extra appeal because they offer a tempting alternative to CDs, which pay virtually no interest at all, and long term bonds, which pay... More »
    November 28, 2009 • ABT, ACL, AMGN
  • 10 Best ETFs (Part 2) by Don Dion
    Picking the best ETFs is just as important as avoiding the most dangerous, which we featured over three days (Part 3, Part 2 and Part 1) last week. The top five exchange-traded funds do things right: capture their theme, provide liquidity and exploit the advantages of the ETF model. New ETF... More »
    September 30, 2009 • SPY, EPI, TIP
  • ETFs a Safer Way to Bet on Health Care by Don Dion
    The uncertainty over the future of health care has exacted a toll on the industry. ETFs like iShares Dow Jones US Healthcare Provider (IHF), Pharmaceutical HOLDRs (PPH) and iShares Biotechnology (IBB) all will be affected differently by changes in legislation. One fact remains indisputable,... More »
    August 19, 2009 • PPH, IBB, IHE
  • Wealth in Healthcare by Don Dion
    In this video, Don Dion tells you what biotechnology ETF is the right prescription for wealth…WATCH HERE
    August 19, 2009 • IBB
  • High beta or Pure Cyclicals by Plant the seeds
    Global markets appear to be trekking back up the mountain and over the valley of fear.  I have been repositioning since about February to ride this wave up (Steady Eddie).  I have been thinking about the relative performance of sectors/segments/industries/regions as stocks recover to... More »
    August 4, 2009 • IBB, GOOG
  • Value and Momentum Strategies in Asset Allocation and Stock Invesment by ValidFi
    In the previous article, we introduced the concept of diversifying along investment strategy styles. In this article, we will discuss value and momentum strategy styles in some detail. Value investment: this has been one of the major styles employed by many famed investors including Warren... More »
    August 2, 2009 • XLU, KBE, IBB
  • Is it the Right Time to Buy Biotechnology Investments? by Sam Subramanian
    July has been a good month for biotech investors. Share prices in the biotech sector as measured by the NYSE Biotechnology Index are up 24% compared to the 6.6% gain for the S&P 500. Earlier in the month, Amgen (AMGN) reported better-than-expected results from a trial of its experimental... More »
    July 27, 2009 • AMGN, BIIB, IBB
  • GILD - some health care please . . by Lee Eugene Munson
    Took a small position in GILD on Friday to get some health care exposure. I was surprised I was outperformed by the big pharma's, but that doesn't last long. While biotech has the beta, I am still in a larger, more mature firm. You can also trade IBB, but it can go in weird directions if a few... More »
    July 26, 2009 • GILD, IBB
  • Something Peculiar.... by Wayne A. Corbitt
    OK folks, I am never one to take things at face value.  It is my job to look under the surface of the market headlines and all of the euphoria to find situations that may give a healthier perspective.  Usually, stepping back and questioning things is good.  Before I go any... More »
    July 24, 2009 • IBB
  • Going into cash by Alex Strashny, Ph.D.
    Peaceful Gains ETFFinancial advisory newsletters withconsistently high long-term returnsJune 28, 2009Update frequency: weeklyAllocationsConservativeCash: 100%BalancedCash: 100% Commentary: Going into cashHappy Fourth of July!Both of the funds that we recommended last week have had excellent... More »
    June 29, 2009 • IBB, FXI

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.